Searchable abstracts of presentations at key conferences in endocrinology

ea0056p273 | Clinical case reports - Thyroid/Others | ECE2018

Hypercalcemia not mediated by PTH: a case report

Zambrano-Huerta Yolanda , Gregorio Oliva-Garcia Jose , Teresa Herrera-Arranz Maria , Olvera-Marquez Pilar , Marquez-Mesa Elena , Lorenzo-Gonzalez Cristina

Introduction: Hypercalcemia is a frequent hydroelectrolytic disorder, and primary hyperparathyroidism is the most common cause in oupatients. It is important to make an early diagnosis and adequate treatment in order to avoid possible complications such as nephrolithiasis, osteoporosis or the deterioration of glomerular filtration rate.Clinical case: A 63-year-old female patient referred for hypercalcemia. Past medical history included stage IV chronic r...

ea0081p166 | Pituitary and Neuroendocrinology | ECE2022

Pasireotide imaging study: magnetic resonance imaging as a predictor of therapeutic response in acromegaly

Ruiz Sabina , Venegas Moreno Eva , Gil Joan , CAMARA ROSA , Biagetti Betina , Angeles Galvez Moreno Maria , Maraver Silvia , Gonzalez-Molero Inmaculada , Pico-Alfonso Antonio , Abellan Galiana Pablo , trincado pablo , Teresa Herrera Arranz Maria , Olvera Pilar , Xifra Villarroya Gemma , Bernabeu Ignacio , Azriel Mira Sharona , Garcia-GarciA-Doncel Lourdes , Jorda Mireia , Valassi Elena , Puig-Domingo Manel

Background: T2-weighted magnetic resonance imaging (MRI) signal has been recently linked with a better tumor response to pasireotide treatment in patients with acromegaly (ACRO). Our aim was to evaluate the prevalence of this radiological feature and its association to therapeutic outcomes in a large cohort of ACRO patients treated with pasireotide.Methods: A retrospective multicentre study was performed in 15 Spanish tertiary university hospitals includ...